Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia - Concepedia

Concepedia

Publication | Closed Access

Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia

25

Citations

64

References

2021

Year

Mari Hashimoto, Yoriko Saito, Ryo Nakagawa, Ikuko Ogahara, Shinsuke Takagi, Sadaaki Takata, Hanae Amitani, Mikiko Endo, Hitomi Yuki, Jordan A. Ramilowski,

Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyHematologyMaximal Therapeutic EfficacyAdult T-cell Leukemia-lymphomaMedicineCell BiologyCancer ResearchMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1